Details for New Drug Application (NDA): 203844
✉ Email this page to a colleague
The generic ingredient in RIVASTIGMINE TARTRATE is rivastigmine tartrate. There are thirty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the rivastigmine tartrate profile page.
Summary for 203844
Tradename: | RIVASTIGMINE TARTRATE |
Applicant: | Cadila Pharms Ltd |
Ingredient: | rivastigmine tartrate |
Patents: | 0 |
Pharmacology for NDA: 203844
Mechanism of Action | Cholinesterase Inhibitors |
Suppliers and Packaging for NDA: 203844
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 203844 | ANDA | Cadila Pharmaceuticals Limited | 71209-012 | 71209-012-03 | 60 CAPSULE in 1 BOTTLE (71209-012-03) |
RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 203844 | ANDA | Cadila Pharmaceuticals Limited | 71209-012 | 71209-012-10 | 500 CAPSULE in 1 BOTTLE (71209-012-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 1.5MG BASE | ||||
Approval Date: | Feb 13, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 3MG BASE | ||||
Approval Date: | Feb 13, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 4.5MG BASE | ||||
Approval Date: | Feb 13, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription